Clinical Validity of Autosomal Dominant ALPK3 Loss-of-Function Variants as a Cause of Hypertrophic Cardiomyopathy

Sophie Hespe, Emma S. Singer, Chloe Reuter, Brittney Murray, Elizabeth Jordan, Jessica Chowns, Stacey Peters, Megan Mayers, Belinda Gray, Ray E. Hershberger, Anjali Owens, Christopher Semsarian, Amber Waddell, Babken Asatryan, Emma Owens, Courtney Thaxton, Mhy-Lanie Adduru, Kailyn Anderson, Emily E. Brown, Lily Hoffman-AndrewsFergus Stafford, Richard D. Bagnall, Lucas Bronicki, Bert Callewaert, C. Anwar A. Chahal, Cynthia A. James, Olga Jarinova, Andrew P. Landstrom, Elizabeth M. Mcnally, Laura Muiño-Mosquera, Victoria Parikh, Roddy Walsh, Bess Wayburn, James S. Ware, Benjamin L. Parker, Enzo R. Porrello, David A. Elliott, James W. Mcnamara, Jodie Ingles*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numbere004976
JournalCirculation: Genomic and Precision Medicine
Volume18
Issue number3
Early online date2025
DOIs
Publication statusPublished - 1 Jun 2025

Keywords

  • cardiac
  • cardiomyopathy
  • exons
  • hypertrophic
  • myocytes
  • phenotype
  • protein kinases

Cite this